AU Patent

AU1063497A — 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives

Assigned to Wyeth LLC · Expires 1997-06-19 · 29y expired

What this patent protects

Patent listed against Xtandi.

Drugs covered by this patent

Patent Metadata

Patent number
AU1063497A
Jurisdiction
AU
Classification
—
Expires
1997-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.